Orphazyme reports business highlights and financial results
Orphazyme A/SFirm announcementNo. 21/2021CVR No.: 32266355 Copenhagen, Denmark, August 31, 2021 – Orphazyme A/S (ORPHA.CO; ORPH) (“the Firm”), a late-stage biopharmaceutical firm, immediately publicizes its Interim Report First Half 2021 for the interval January 1...
Read more








